VIX
19
-6
DG
30
-2
BF.B
48
-3
AZO
52
2
ALLE
25
-3
VLO
33
-2
M
27
2
PEP
38
2
PG
60
2
PX
46
4
AMZN
58
-2
CNP
65
3
LRCX
83
2
EXC
40
5
STT
44
4
EBAY
45
2
IBM
74
2
HUM
28
-6
MAC
60
3
SLB
44
5
VIX
19
-6
DG
30
-2
BF.B
48
-3
AZO
52
2
ALLE
25
-3
VLO
33
-2
M
27
2
PEP
38
2
PG
60
2
PX
46
4
AMZN
58
-2
CNP
65
3
LRCX
83
2
EXC
40
5
STT
44
4
EBAY
45
2
IBM
74
2
HUM
28
-6
MAC
60
3
SLB
44
5
Financhill
Back

First Citizens BancShares Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

FCNCA
First Citizens BancShares

Last Price:
1,641.00
Seasonality Move:
2.51%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
41
First Citizens BancShares (FCNCA) is a Sell

Is First Citizens BancShares a Buy, Sell or Hold?

  • The current First Citizens BancShares [FCNCA] share price is $1,639.71. The Score for FCNCA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FCNCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCNCA Stock Price Chart

What is First Citizens BancShares's stock price today?

  • The First Citizens BancShares share price today is $1,639.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCNCA is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

FCNCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -17.95 Sell
Relative Strength Index (14 RSI): 39.82 Sell
Chaikin Money Flow: -55563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1661 - 1760.02) Sell
Bollinger Bands (100): (1526.91 - 1706.13) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

FCNCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1654.32 Sell
20-day SMA: 1700.73 Sell
50-day SMA: 1684.33 Sell
200-day SMA: 1505.21 Buy
8-day EMA: 1655.7 Sell
20-day EMA: 1681.18 Sell
50-day EMA: 1672.36 Sell
200-day EMA: 1510.26 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

First Citizens BancShares Earnings Growth & FCNCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.83 per share, a decrease next quarter of $0.43 per share, an increase this year of $12.55 per share, and an increase next year of $5.79 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

First Citizens BancShares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):